The precipitous cancellation of Australia’s Economic Accelerator (AEA) this month, alongside the redirection of $800 million in uncommitted funding, has sent a shock wave through their research, science and technology sector.
Currently, less than one percent of clothing is recycled back into new garments. A Stockholm-based deep-tech is joining the global charge towards re-processing mountains of textile waste.
Synthetic biology startup Bontia Bio focuses on creating sustainable, nature-based treatments for animal health. The New Zealand veterinary bio-pharmaceutical startup is providing non-toxic relief from flea and tick infestation for our furry friends.
Paris based company Standing Ovation specialises in producing animal-free casein through precision fermentation. They just raised an impressive €30 million as part of French efforts to preserve technical sovereignty and secure future food supply.
UK-Portugal greentech venture Arborea is bridging the gap between design engineering and biotechnology with a synthetic leaf that creates food directly from sunlight.
A New Zealand university spinoff venture has a bold vision to extract and recycle critical minerals from industrial waste.
The 2026 Denholm Review — formally titled Ambitious Australia — issues a blunt wake-up call. The nation’s R&D system is too fragmented and risk-averse to sustain future living standards and must transition into a “smart country”.
New Zealand deep tech startup Wellumio is developing a portable NMR scanner that delivers quicker patient care and better outcomes.
It has been a huge start to the year for Carbonaide CEO Tapio Vehmas. His carbon sequestration venture not only secured a €3.7 million funding round, but also set up its first industrial scale production facility. And if that wasn’t success enough, a block of certified carbon credits from the process were also minted and…
